According to federal traffic safety data, the number of deaths on U.S. roads has decreased significantly in recent years. However, the decline in fatal car accidents is not due to safer and more conscientious driving habits, but to innovative safety features in new vehicles.
According to a recently released document, New Jersey company Johnson & Johnson began taking action to phase out the use of its metal-on-metal artificial hips just weeks after the receiving a letter from U.S. Food and Drug Administration. In that letter, the agency reportedly turned down Johnson's application to sell the medical product in the United States, and told the company to submit additional safety data if it wanted to pursue the application.
As we previously discussed, several members of Congress are working to close a loophole in the U.S. Food and Drug Administration's approval process. Currently, the 501(k) process requires the FDA to approve medical devices if a manufacturer can show that the device is similar to one that has already been approved for sale.
In recent weeks, we have written extensively on the issues surrounding the DePuy Orthopaedics articular surface replacement (ASR) metal-on-metal hip replacement joints. Essentially, these faulty medical products have caused thousands of people in New Jersey and throughout the country to suffer debilitating pain and lasting injury as a result of friction in the joint's metal components.
Although this case did not take place in New Jersey, it provides a unique example of the potentially life-changing harm that can take place following a misdiagnosis of breast cancer. Normally, plaintiffs file medical malpractice lawsuits after doctors have failed to properly diagnose them, causing them to wait to seek treatment until their diseases are irreversibly advanced.
Pedestrians who walk along older state highways are at a greater risk of being fatally struck by a motor vehicle, according to a new report. This increased pedestrian accident rate is present even on streets with sidewalks, indicating that New Jersey transportation need to do more to make streets safer for walkers and bicyclists.
Earlier this week, we talked about the loophole in the U.S. Food and Drug Administration's 510(k) medical device approval process which reportedly allowed for the approval of a vaginal mesh product manufactured by New Jersey-based Johnson & Johnson. Recently, members of the U.S. House of Representatives proposed a bill which, if passed, would close that loophole, effectively preventing devices based on dangerous, previously-recalled medical products from being approved by the FDA.
Last month, we wrote about federal legislators' efforts to close the loophole in the U.S. Food and Drug Administration's medical device approval process. Now, it appears that a top official with the device division of the FDA agrees that such a change should be made. Hopefully, this will spur the legislation and prevent dangerous or defective products from making it to the marketplace in the future.
In 2005, a 16-year-old New Jersey teenager was paralyzed from the chest down in a single-car crash when the vehicle in which she was a passenger slammed into a telephone pole. A police investigation later revealed that road rage was responsible for the car accident. After being cut off by another vehicle, the driver of the car in which the girl was a passenger began speeding and weaving through traffic, and ultimately crashed the car.